Dividend update
BLUEJET · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.0 pts more than Nifty Smallcap 250 and 9.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Blue Jet Healthcare's Board approved FY2026 standalone results showing total income of Rs. 10,762.41 million and net profit after tax of Rs. 3,052.03 million, down from Rs. 2,478.16 million in the prior year — a ~23% decline. The Board recommended a final dividend of Rs. 1.2 per share (60% of face value Rs. 2), subject to shareholder approval at the AGM. No record date or payment date has been fixed yet. Separately, the Board approved a proposal to raise up to Rs. 10,000 million (Rs. 1,000 crore) through QIP, preferential issue, private placement, or other permitted modes — with timing, pricing, and tranche details to be decided later.
Profit declined year-on-year, which may concern investors; however, the dividend declaration signals continued cash distribution. The large fund-raising proposal could dilute existing shareholders if executed and will require close monitoring of terms.